维普中文期刊产品整合服务
159篇 您的检索式:作者名="Asselah"
    题名 作者 年代 出处 被引量
1Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis显示文摘Ana-Carolina Cardoso Rami Moucari Claudio Figueiredo-Mendes Marie-Pierre Ripault Nathalie Giuily Corinne Castelnau Nathalie Boyer Tarik Asselah Michelle Martinot-Peignoux Sarah Maylin Roberto J. Carvalho-Filho Dominique Valla Pierre Bedossa Patrick Marcel 2010Journal of Hepatology2010,,5:3
2HB sAg quantification: useful for monitoring natural history and treatment outcome显示文摘Michelle Martinot‐Peignoux Martine Lapalus Tarik Asselah Patrick Marcellin 2014Liver Int2014,,:3
3O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY显示文摘N. Afdhal G. Everson J.L. Calleja G. McCaughan W.T. Symonds J. Denning L. McNair J.G. McHutchison S. Arterburn M. Charlton R. Reddy T. Asselah E. Gane X. Forns 2014Journal of Hepatology2014,,1:3
4HCV direct‐acting antiviral agents: the best interferon‐free combinations显示文摘Raymond Schinazi Philippe Halfon Patrick Marcellin Tarik Asselah 2014Liver Int2014,,:2
5<ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick 2008Gastroenterology2008,,2:2
6High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study显示文摘Rami Moucari Anneke Korevaar Olivier Lada Michelle Martinot-Peignoux Nathalie Boyer Vincent Mackiewicz Agnes Dauvergne Ana C. Cardoso Tarik Asselah Marie-Hélène Nicolas-Chanoine Michel Vidaud Dominique Valla Pierre Bedossa Patrick Marcellin 2009Journal of Hepatology2009,,6:2
7The role of HBsAg quantification for monitoring natural history and treatment outcome显示文摘Michelle Martinot‐Peignoux Martine Lapalus Tarik Asselah Patrick Marcellin 2013Liver Int2013,,:2
8Long‐term therapy for chronic hepatitis B : Hepatitis B virus DNA suppression leading to cirrhosis reversal显示文摘Patrick Marcellin Tarik Asselah 2013J Gastroenterol Hepatol2013,,6:2
9Genomics and HCV infection: Progression of fibrosis and treatment response显示文摘Emilie Estrabaud Michel Vidaud Patrick Marcellin Tarik Asselah 2012Journal of Hepatology2012,,5:2
10Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data显示文摘Gioacchino Leandro Alessandra Mangia Jason Hui Paolo Fabris Laura Rubbia–Brandt Guido Colloredo Luigi E. Adinolfi Tarik Asselah Julie R. Jonsson Antonina Smedile Norah Terrault Valerio Pazienza Maria Teresa Giordani Emiliano Giostra Aurelio Sonzogni Giuse 2006Gastroenterology2006,,6:2
11CMV drives elonal expansion of NKG2Cq- NK cells expressing self-specific KIRs in chronic hepatitis patients 显示文摘B6ziat V Dalgard O Asselah T 2012Eur J Immunol2012,42,2:1
12Molecular profiling of early stage liver fibrosis in patients with chronie hepatitis C virus infection显示文摘BIECHE I ASSELAH T LAURENDEAU I 2005Virology2005,332,:1
13Fibrosis and dis- ease progression in hepatitis C 显示文摘MARCELLIN P ASSELAH T BOYER N 2002Hepatology2002,36,51:1
14Portal cavernoma-associated cholangiopathy:a clinical and MR cholangiography coumpled with MR portography imaging study显示文摘Condat B Vilgrain V Asselah T 2003Hepatology2003,37,6:1
15The Current Status of Antiviral Therapy of Chronic Hepatitis B显示文摘ASSELAH T RIPAULT MP CASTELNAU C 2005J Clin Virol(S1386-6532)2005,34,1:1
16Treatment of chro-nic hepatitis B显示文摘ASSELAH T LADA O MARCELLIN P 2011Rev Prat2011,61,1:1
17Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT显示文摘Ronot M Asselah T~ Paradis V 2010Radiology2010,256,1:1
18Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial 显示文摘Hézode C Asselah T Reddy KR 2015Lancet2015,385,:1
19The current status of antiviral therapy of chronic hepatitis B显示文摘Tarik Asselah Marie-Pierre Ripault Corinne Castelnau 2005Journal of Clinical Virology2005,11,:1
20The current status of antiviral therapy of chronic hepatitis B显示文摘Asselah T Ripault M P Castelnau C 2005J Clin Virol2005,34,1:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费